This inventor holds 1 USPTO granted patent. Top assignees: Merck Sharp + Dohme Corp., Pfizer Corporation. Active years: 2020.
Company Filing History:
1 out of 2,405 
1 out of 4,486 
Years Active: 2020
Title: Leena Das-Young: Innovator in Cancer Treatment
Introduction
Leena Das-Young is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on combination therapies that target specific cancer pathways, showcasing her dedication to improving patient outcomes.
Latest Patents
Leena holds a patent for a groundbreaking invention titled "Combination of a PD-1 antagonist and an ALK inhibitor for treating cancer." This patent describes combination therapies that include an antagonist of the Programmed Death 1 receptor (PD-1) and an Anaplastic Lymphoma Kinase (ALK) inhibitor. The therapies are designed for the treatment of cancers that test positive for ALK, PD-L1, or both ALK and PD-L1. Leena's innovative approach has the potential to enhance the effectiveness of cancer treatments.
Career Highlights
Throughout her career, Leena has worked with leading pharmaceutical companies, including Pfizer Corporation and Merck Sharp & Dohme Corp. Her experience in these organizations has equipped her with the knowledge and skills necessary to drive advancements in cancer therapies. Leena's commitment to research and development has positioned her as a key player in the field.
Collaborations
Leena has collaborated with notable professionals in her field, including Steffan Nicholas Ho and Keith David Wilner. These collaborations have allowed her to expand her research and contribute to innovative solutions in cancer treatment.
Conclusion
Leena Das-Young is a trailblazer in the realm of cancer treatment, with her patent and collaborations reflecting her commitment to innovation. Her work continues to inspire advancements in medical research and therapy development.